ArticleWorld journal of clinical cases2022

Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy.

Samuel J S Rubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.